Work

Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies

Year: 2019

Type: article

Source: Toxicologic Pathology

DOI: 10.1177/0192623319835170

Authors: Natalie D. Keirstead, Evan B. Janovitz, James T. Meehan, Bruce E. LeRoy, John R. Megill, Richard A. Peterson, Regis G. Masson, Heike A. Marxfeld

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Bristol-Myers Squibb (United States), AbbVie (United States), BASF (Germany)

Language: English

Topic: Immunotoxicology and immune responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2942414094

FWCI: 0.299

Cites: 3

Cited by: 5

Related to: 10